Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cti Biopharm Corp (NQ: CTIC )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cti Biopharm Corp

< Previous 1 2 3 4 Next >
Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer. 
Via Investor's Business Daily
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
From Kahn Swick & Foti, LLC
Via Business Wire
CTI BioPharma Corp. (NASDAQ: CTIC) Climbs to New 52-Week High
Via Investor Brand Network
Top 5 Health Care Stocks That Should Keep You Up At Night
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
Via Benzinga
The Latest Analyst Ratings for CTI BioPharma
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
From Kahn Swick & Foti, LLC
Via Business Wire
Dow Falls 90 Points; Mesa Air Group Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1% points on Wednesday. The Dow traded down 0.27% to 33,471.60 while the NASDAQ rose 1.01% to 12,302.61. The... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq, S&P 500 Higher As Bond Yields Retreat
Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April. 
Via Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH)
From Brodsky & Smith LLC
Via GlobeNewswire
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
Crude Oil Down 1%; Microvast Holdings Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded down 0.28% to 33,469.12 while the NASDAQ rose 0.75% to 12,270.95. The S&P... 
Via Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
CTI BioPharma Corp. (NASDAQ: CTIC) Near Top of Volume Charts in Wednesday Trading
Via Investor Brand Network
Why Shares of CTI BioPharma Are Soaring Wednesday
A buyout offer from Swedish Orphan Biovitrum drove up the stock's price. 
Via The Motley Fool
Nasdaq Surges Over 1%; US Inflation Falls In April
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Wednesday. 
Via Benzinga
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is SeaStar Medical (ICU) Stock Down 32% Today?
SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA. 
Via InvestorPlace
Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday. 
Via Benzinga
CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Is Babylon (BBLN) Stock Down 57% Today?
Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private. 
Via InvestorPlace
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi. 
Via InvestorPlace
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! 
Via InvestorPlace
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
Incyte Corporation (NASDAQ: INCY) will report Q1 FY23 results on May 2.  Investor focus remains on the Opzelura launch, which has faced some hiccups over the first 18 months of launch and began to gain... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.